Related references
Note: Only part of the references are listed.Central Retinal Vein Occlusion 36-Month Outcomes with Anti-VEGF The Fight Retinal Blindness! Registry
Adrian Hunt et al.
OPHTHALMOLOGY RETINA (2023)
Real-World Evidence for Regulatory Decision-Making: Guidance From Around the World
Leah Burns et al.
CLINICAL THERAPEUTICS (2022)
Long-term outcomes of anti-VEGF treatment of macular oedema due to retinal vein occlusions
Paolo Corazza et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2022)
Long-term outcomes for patients treated for macular oedema secondary to retinal vein occlusion: a systematic review
Alexandra Hunter et al.
BMJ OPEN OPHTHALMOLOGY (2022)
Efficacy and safety of aflibercept therapy for diabetic macular edema: A systematic review and meta-analysis
Sangeetha Santhakumaran et al.
JOURNAL OF CURRENT OPHTHALMOLOGY (2022)
A novel tool to assess the quality of RWE to guide the management of retinal disease
Robert P. Finger et al.
ACTA OPHTHALMOLOGICA (2021)
Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend for Macular Edema in Central Retinal Vein Occlusion: the CENTERA Study
Jean-Francois Korobelnik et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2021)
Individualized treat-and-extend regime for optimization of real-world vision outcome and improved patients' persistence
Ingo Volkmann et al.
BMC OPHTHALMOLOGY (2020)
Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors
Peige Song et al.
JOURNAL OF GLOBAL HEALTH (2019)
Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion A Randomized Clinical Trial
Philip Hykin et al.
JAMA OPHTHALMOLOGY (2019)
Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy - a systematic approach to identify and characterize data sources
Vincent Daien et al.
BMC OPHTHALMOLOGY (2019)
Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN study
Catharina Busch et al.
ACTA DIABETOLOGICA (2019)
Guidelines for the Management of Retinal Vein Occlusion by the European Society of Retina Specialists (EURETINA)
Ursula Schmidt-Erfurth et al.
OPHTHALMOLOGICA (2019)
Strategies of Intravitreal Injections with Anti-VEGF: Pro re Nata versus Treat and Extend
K. Hufendiek et al.
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE (2018)
Mechanisms of macular edema: Beyond the surface
Alejandra Daruich et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2018)
Integrated results from the COPERNICUS and GALILEO studies
Amelie Pielen et al.
CLINICAL OPHTHALMOLOGY (2017)
Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion 52-Week Results of the VIBRANT Study
W. Lloyd Clark et al.
OPHTHALMOLOGY (2016)
Prevalence and risk factors of retinal vein occlusion: the Gutenberg Health Study
K. A. Ponto et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Is it time to confine Snellen charts to the annals of history?
Jan E. Lovie-Kitchin
OPHTHALMIC AND PHYSIOLOGICAL OPTICS (2015)
Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion The 24-Week Results of the VIBRANT Study
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2015)
Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion: 18-Month Results of the Phase 3 GALILEO Study
Yuichiro Ogura et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2014)
Intravitreal Aflibercept Injection for Macular Edema Resulting from Central Retinal Vein Occlusion One-Year Results of the Phase 3 GALILEO Study
Jean-Francois Korobelnik et al.
OPHTHALMOLOGY (2014)
Intravitreal Aflibercept Injection for Macular Edema Due to Central Retinal Vein Occlusion
Jeffrey S. Heier et al.
OPHTHALMOLOGY (2014)
Reproducibility of Spectral-Domain Optical Coherence Tomography Retinal Thickness Measurements and Conversion to Equivalent Time-Domain Metrics in Diabetic Macular Edema
Susan B. Bressler et al.
JAMA OPHTHALMOLOGY (2014)
Intravitreal Aflibercept Injection for Macular Edema Secondary to Central Retinal Vein Occlusion: 1-Year Results From the Phase 3 COPERNICUS Study
David M. Brown et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2013)
VEGF Trap-Eye for macular oedema secondary to central retinal vein occlusion: 6-month results of the phase III GALILEO study
Frank G. Holz et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2013)
Vascular Endothelial Growth Factor Trap-Eye for Macular Edema Secondary to Central Retinal Vein Occlusion Six-Month Results of the Phase 3 COPERNICUS Study
David Boyer et al.
OPHTHALMOLOGY (2012)
The burden of disease of retinal vein occlusion: review of the literature
M. Laouri et al.
EYE (2011)
Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion Six-Month Primary End Point Results of a Phase III Study
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2010)
Ranibizumab for Macular Edema following Central Retinal Vein Occlusion
David M. Brown et al.
OPHTHALMOLOGY (2010)
NOVEL METHOD FOR ANALYZING SNELLEN VISUAL ACUITY MEASUREMENTS
Ninel Z. Gregori et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
Responsiveness of NEI VFQ-25 to Changes in Visual Acuity in Neovascular AMD: Validation Studies from Two Phase 3 Clinical Trials
Ivan J. Suner et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Evaluation of minimum clinically meaningful changes in scores on the national eye institute visual function questionnaire (NEI-VFQ) SST report number 19
Paivi H. Miskala et al.
OPHTHALMIC EPIDEMIOLOGY (2007)
Changes in visual acuity in a population over a 15-year period: The Beaver Dam Eye Study
Ronald Klein et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2006)
Development and initial validation of the Falls Efficacy Scale-International (FES-I)
L Yardley et al.
AGE AND AGEING (2005)
Development of the 25-item National Eye Institute Visual Function Questionnaire
CM Mangione et al.
ARCHIVES OF OPHTHALMOLOGY (2001)
Share Paper
